We and others previously supported the existence of a “cancer stem cell” subpopulation (CSC) in brain tumours, including MDB, expressing phenotypic markers generally associated to neural stem cells in the developing brain, such as CD133 and Nestin. Here, ABR is linked to brain neoplasm.